Gilead Foundation Awards $20 Million to Organizations Working to Advance Health Through Education Equity Pharmaceutical Investing
Allergan Aesthetics and BOTOX® Cosmetic Reveal New 'See Yourself' Campaign Cast, Spotlighting 25 Real People and Their Stories Pharmaceutical Investing
Strata Oncology Announces Expansion of Clinical Collaboration with Pfizer for Strata PATH Trial into Early-Stage Cancer Pharmaceutical Investing
Health Canada Approves KEYTRUDA® as Adjuvant Treatment for Adults and Children with Stage IIB or IIC Melanoma Following Complete Resection Pharmaceutical Investing
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union Pharmaceutical Investing
Astellas, Seagen and Merck Announce Results of Clinical Trial Investigating PADCEV® with KEYTRUDA® and PADCEV as Monotherapy in First-Line Advanced Urothelial Cancer Pharmaceutical Investing
Seagen, Astellas and Merck Announce Results of Clinical Trial Investigating PADCEV® with KEYTRUDA® and PADCEV as Monotherapy in First-Line Advanced Urothelial Cancer Pharmaceutical Investing
Five-Year Data for Merck's KEYTRUDA® Plus Chemotherapy Showed Sustained Survival Benefit Versus Chemotherapy Alone in Two Studies for Metastatic Non-Small Cell Lung Cancer Pharmaceutical Investing
New Late-Breaking Results from Phase 3 Trials of SKYRIZI® Evaluating Long-term Effect on Skin and Joint Symptoms in Patients with Psoriatic Arthritis at Week 100 Pharmaceutical Investing
Bristol Myers Squibb Announces New Sotyktu Long-Term Data Showing Clinical Efficacy Maintained for Up to Two Years with Continuous Treatment in Moderate-to-Severe Plaque Psoriasis Pharmaceutical Investing
Merck and Eisai Present Results From Phase 3 LEAP-002 Trial Evaluating KEYTRUDA® Plus LENVIMA® Versus LENVIMA Monotherapy in Patients With Unresectable Hepatocellular Carcinoma Pharmaceutical Investing
  U.S. Food and Drug Administration Approves Sotyktu , Oral Treatment for Adults with Moderate-to-Severe Plaque Psoriasis Pharmaceutical Investing
